Test Price
2,800 AED✅ Home Collection Available
GUCY1A3 Gene NGS Test for Moyamoya Type 6 with Achalasia in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GUCY1A3 لمرض مويامويا النوع السادس مع تعذر الارتخاء المريئي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing.
- Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain transport; VIP mobile phlebotomy available.
- Clinical Guidance: Complimentary tele‑clinical post‑test consultation to interpret results with a medical geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معايير ISO، مع خدمة جمع منزلي معتمدة واستشارة طبية بعد النتيجة.
Overview of the GUCY1A3 Gene Test
The GUCY1A3 Next‑Generation Sequencing (NGS) test detects pathogenic variants in the gene encoding soluble guanylate cyclase, which is associated with Moyamoya disease type 6 and achalasia. This advanced genomic analysis provides a definitive molecular diagnosis, enabling tailored surveillance and early intervention for affected individuals.
How Our UAE Test Compares
| Feature | Our UAE NGS Test | Closest Alternative (Overseas Referral) |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | Variable; often 95‑98% with older panels |
| Method | Full‑gene NGS (Illumina® platform) | Sanger sequencing or targeted partial‑gene analysis |
| Turnaround Time | 3–4 weeks | 4–6 weeks plus international shipping delays |
| Genetic Counselling | In‑house, DHA‑licensed pre‑ and post‑test | Often not available or requires separate referral |
| Local Regulatory Compliance | Full DHA/MOHAP adherence | May not align with UAE genetic data laws |
Physician Insight & Safety Protocol
“As a DHA‑licensed Clinical Geneticist, I emphasize that this test identifies mutations in GUCY1A3 strongly linked to Moyamoya type 6 with achalasia; however, a negative result does not exclude other genetic or acquired causes of these conditions. Clinical correlation with brain imaging, gastroenterology assessment, and family history remains essential. Always discuss your results with a specialist before altering any medical management.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠ Important Medication Warning: Do not discontinue prescribed medications (e.g., antiplatelets, proton pump inhibitors) without consulting your treating physician. Genetic results inform risk, not immediate therapy changes.
Safety Alerts & Red Flags
- Exclusion Criteria: Inability to provide informed consent; refusal of genetic counselling; acute febrile illness at the time of blood draw; prior bone marrow transplant (may affect DNA source).
- Emergency Red Flags: Sudden onset of stroke‑like symptoms (limb weakness, facial droop, speech difficulty); severe dysphagia with weight loss; transient vision loss – seek immediate emergency care.
Patient FAQ & Clinical Guidance
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians